Partners

The PHAGO Consortium is composed of research organisations from basic to clinical research and industrial research units, all focussing on Alzheimer's disease, and thus provides the scientific expertise, facilities, networks and experience to achieve the project goals.

Led by Janssen Pharmaceutica NV and coordinated by University Hospital of Bonn, the Consortium comprises 8 pharmaceutical companies (as members of the European Federation of Pharmaceutical Industries and Associations - EFPIA), 3 small/medium size enterprises (SMEs) and 8 universities/public research organisations.

Home
Menu
Top
 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.

Social Media

PHAGO by Twitter PHAGO by LinkedIn

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.